These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28628234)

  • 21. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice.
    Matsumoto Y; Miwa S; Zhang Y; Zhao M; Yano S; Uehara F; Yamamoto M; Hiroshima Y; Toneri M; Bouvet M; Matsubara H; Tsuchiya H; Hoffman RM
    Oncotarget; 2015 May; 6(13):11369-77. PubMed ID: 25957417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods for Tumor Targeting with Salmonella typhimurium A1-R.
    Hoffman RM; Zhao M
    Methods Mol Biol; 2016; 1409():143-64. PubMed ID: 26846809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX).
    Hiroshima Y; Zhao M; Maawy A; Zhang Y; Katz MH; Fleming JB; Uehara F; Miwa S; Yano S; Momiyama M; Suetsugu A; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    J Cell Biochem; 2014 Jul; 115(7):1254-61. PubMed ID: 24435915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Kawaguchi K; Igarashi K; Murakami T; Zhao M; Zhang Y; Chmielowski B; Kiyuna T; Nelson SD; Russell TA; Dry SM; Li Y; Unno M; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Aug; 118(8):2314-2319. PubMed ID: 28106277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-targeting
    Kiyuna T; Tome Y; Uehara F; Murakami T; Zhang Y; Zhao M; Kanaya F; Hoffman RM
    Anticancer Res; 2018 Jan; 38(1):159-164. PubMed ID: 29277768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice.
    Zhang Y; Zhang N; Zhao M; Hoffman RM
    Oncotarget; 2015 Jun; 6(16):14625-31. PubMed ID: 25714030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcoma.
    Kiyuna T; Tome Y; Murakami T; Zhao M; Miyake K; Igarashi K; Kawaguchi K; Miyake M; Oshiro H; Higuchi T; Li Y; Dry SM; Nelson SD; Russell TA; Eckardt MA; Singh AS; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Sep; 119(9):7827-7833. PubMed ID: 29932244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmonella typhimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.
    Hoffman RM; Yano S
    Methods Mol Biol; 2016; 1409():165-75. PubMed ID: 26846810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.
    Toneri M; Miwa S; Zhang Y; Hu C; Yano S; Matsumoto Y; Bouvet M; Nakanishi H; Hoffman RM; Zhao M
    Oncotarget; 2015 Oct; 6(31):31335-43. PubMed ID: 26431498
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Hamada K; Aoki Y; Yamamoto J; Hozumi C; Zhao M; Murata T; Sugisawa N; Bouvet M; Tsunoda T; Hoffman RM
    In Vivo; 2021; 35(6):3067-3071. PubMed ID: 34697138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice.
    Nagakura C; Hayashi K; Zhao M; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Bouvet M; Hoffman RM
    Anticancer Res; 2009 Jun; 29(6):1873-8. PubMed ID: 19528442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture.
    Zhang Y; Zhang N; Su S; Hoffman RM; Zhao M
    Anticancer Res; 2013 May; 33(5):1837-43. PubMed ID: 23645728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Zhang Y; Zhao M; Li Y; Bouvet M; Kanaya F; Singh A; Dry S; Eilber FC; Hoffman RM
    Oncotarget; 2016 May; 7(22):33046-54. PubMed ID: 27105519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicology and efficacy of tumor-targeting
    Zhang Y; Cao W; Toneri M; Zhang N; Kiyuna T; Murakami T; Nelson SD; Dry SM; Li Y; Li S; Wang X; Ma H; Singh AS; Eilber FC; Hoffman RM; Zhao M
    Oncotarget; 2017 Aug; 8(33):54616-54628. PubMed ID: 28903369
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor-targeting
    Miyake K; Kawaguchi K; Miyake M; Zhao M; Kiyuna T; Igarashi K; Zhang Z; Murakami T; Li Y; Nelson SD; Bouvet M; Elliott I; Russell TA; Singh AS; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Singh SR; Endo I; Eilber FC; Hoffman RM
    Heliyon; 2018 Jun; 4(6):e00643. PubMed ID: 30003151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice.
    Zhang Y; Tome Y; Suetsugu A; Zhang L; Zhang N; Hoffman RM; Zhao M
    Anticancer Res; 2012 Jul; 32(7):2501-8. PubMed ID: 22753706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model.
    Momiyama M; Zhao M; Kimura H; Tran B; Chishima T; Bouvet M; Endo I; Hoffman RM
    Cell Cycle; 2012 Feb; 11(3):628-32. PubMed ID: 22274398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of tumor-targeting Salmonella typhimurium A1-R and oral recombinant methioninase regresses a BRAF-V600E-negative melanoma.
    Kawaguchi K; Higuchi T; Li S; Han Q; Tan Y; Igarashi K; Zhao M; Miyake K; Kiyuna T; Miyake M; Ohshiro H; Sugisawa N; Zhang Z; Razmjooei S; Wangsiricharoen S; Chmielowski B; Nelson SD; Russell TA; Dry SM; Li Y; Eckardt MA; Singh AS; Singh SR; Eilber FC; Unno M; Hoffman RM
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3086-3092. PubMed ID: 30166061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered Attenuated
    Hyun J; Jun S; Lim H; Cho H; You SH; Ha SJ; Min JJ; Bang D
    ACS Synth Biol; 2021 Oct; 10(10):2478-2487. PubMed ID: 34525796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.